“…2,3 The combination estrogen-gestagen is used for the treatment of estrogenic deficiency syndrome to control its symptoms (climateric syndrome), such as loss of bone minerals and development of heart disease. 4 Up to now, various analytical methods for the determination of EV or MPA have been reported including voltammetry, 1 spectrophotometry, 5,6 fluorometry, 7 high performance liquid chromatography (HPLC), 4,[8][9][10][11] gas chromatography-mass spectrometry (GC-MS), [12][13][14] FT-Raman spectroscopy 15 and chemiluminescence enzyme immunoassay 16 in pharmaceutical preparations and biological liquids. But there has been no GC-MS method reported in the litearature for simultaneous determination of these two hormones in pharmaceutical preparations.…”